2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with dipalmitoylphosphatidic acid in 1 studies
| Studies (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Trials (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Recent Studies (post-2010) (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Studies (dipalmitoylphosphatidic acid) | Trials (dipalmitoylphosphatidic acid) | Recent Studies (post-2010) (dipalmitoylphosphatidic acid) |
|---|---|---|---|---|---|
| 31 | 0 | 6 | 77 | 0 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, T; Kondo, M; Kuromi, K; Matsuda, A; Ogino, K; Oku, N; Shimizu, K; Shuto, S; Taki, T; Watanabe, K | 1 |
1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and dipalmitoylphosphatidic acid
| Article | Year |
|---|---|
Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cytarabine; Drug Delivery Systems; Liposomes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Phosphatidic Acids; Survival Analysis; Time Factors; Tissue Distribution; Treatment Outcome; Tumor Cells, Cultured | 2002 |